Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Mastectomy

ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

About this trial

This study aims to evaluate the effect of serratus posterior superior intercostal plane (SPSIP) block on postoperative pain, opioid consumption, and analgesic requirements in patients undergoing mastectomy and axillary lymph node dissection

Eligibility criteria

Qualifiers

Female patients aged 18-65 years

ASA physical status I-III

Scheduled for elective unilateral mastectomy with axillary lymph node dissection under general anesthesia

Able to understand and use the Numeric Rating Scale (NRS) for pain assessment

Disqualifiers

Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine)

Coagulopathy, thrombocytopenia (<100,000/mm³), or ongoing anticoagulant/antiplatelet therapy that cannot be discontinued

Infection or skin lesion at the injection site

Planned bilateral surgery or additional major surgical procedures

Trial design

Treatments tested in this trial

  • SPSIP Block With Bupivacaine
  • SPSIP Block With Saline

Treatment groups

50 Participants
are divided into 2 treatment groups